GFC partners with Germany's R-biopharm AG

Gulf Scientific Corporation (GSC), a prominent provider of laboratory solutions across analytical, material, and life sciences in the Gulf Cooperation Council (GCC), announced its recent agreement with R-biopharm, a leading biotechnology company from Germany.

This partnership, marks a significant step in expanding GSC’S portfolio in the fields of health, and quality of life through advanced biotechnological analysis. R-biopharm, known for its dedication to consumer and patient health, aligns perfectly with GSC'S ethos. This collaboration aims to bring these high-value solutions to Saudi Arabia, under the analytical line of Gulf Scientific Corporation, a press release said.

With a robust presence in major cities across the Gulf region, Gulf Scientific Corporation, along with its subsidiaries - Sama Masa, Dar Al-aalmiyah, ATP Kuwait, JSC, and Atrium - continues its commitment to providing cutting-edge laboratory solutions. This new venture with RBiopharm will further bolster GSC'S position as a leader in analytical and material sciences within the GCC.

Manaf Afyouni, managing director at Gulf Scientific Corporation, said, “Our strategic alliance with R-biopharm is a testament to our ongoing commitment to the scientific community. This partnership will enable us to offer comprehensive analytical solutions through Sama Masa, and Dar Al-aalmiyah in Saudi Arabia, enhancing our portfolio and furthering our goal to contribute significantly to the scientific advancement and quality of life.”

The partnership between Gulf Scientific Corporation and R-biopharm in Saudi Arabia is poised to set a new standard in the region's analytical and biotechnology landscape, delivering top-tier biotechnological services.